How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

10,809 results for

Management of Severe Head Injury

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

10561. Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients

of severe head injury, continuous intrathecal baclofen infusion will be delivered. The first week of study is double-blind: the first of two parallel groups receives CIBT and the second group receives placebo. The main outcome (number of neurovegetative episodes) is assessed at the end of first week. The second week of study is open labeled: active treatment is continued in the first group and the second group starts active CIBT treatment. The third week of study, treatment is stopped in both groups (...) Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2005 Clinical Trials

10562. MR Scanning of Very Young Children With Severe Developmental Disorders

MR Scanning of Very Young Children With Severe Developmental Disorders MR Scanning of Very Young Children With Severe Developmental Disorders - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. MR Scanning (...) , a language disorder or mental retardation Exclusion Criteria: Significant motor or sensory impairment Major physical abnormalities History of serious head injury Identifiable neurologic disorder Metal implants Contraindication for MRI Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov

2005 Clinical Trials

10563. Prehospital endotracheal intubation in adult major trauma patients with head injury

with isolated severe head injruy 49.6% versus 22.8% OR 3 Davis DP et al, 2005 USA 13, 625 patients with moderate to severe traumatic brain injury included on a country trauma registry of whom 19.3% were intubated in the prehospital environment Observational Mortality Increased with prehospital intubation (OR 0.36 p Comment(s) Quite a few studies have been conducted to address the question of prehospital endotracheal intubation in major trauma victims needing airway management. All of them (...) November 2005 Last Modified: 8th May 2005 Status: Green (complete) Three Part Question In [patients with major trauma and head injury needing airway management in prehospital setting] is [endotracheal intubation better than bag and mask ventilation] for [improved outcomes] Clinical Scenario A 41 year old car driver was involved in a major road traffic accident, sustaining injuries to his head, a fracture of his right femur and multiple bruises on his chest. On scene he had altered sensorium and his GCS

2005 BestBETS

10564. BAES Guidelines on Training and Management of Endocrine Disease

are advised.Guidelines for the Surgical Management of Endocrine Disease 5 MULTINODULAR GOITRE * Biochemical toxicity must be controlled prior to surgery. * Unilateral surgery may be indicated when only one lobe is severely affected but, when there is significant involvement of both lobes, then total/near total thyroidectomy is recommended. * Recurrent laryngeal nerves must be clearly identified and safeguarded. The superior laryngeal nerve on each side should be safeguarded by careful ligation of the superior (...) with more radical surgery for malignant disease (viz hypoparathyroidism and recurrent laryngeal nerve injury). See Section 6.1. SURGICAL TREATMENT * The objective of surgery is to remove all macroscopic malignant disease in the thyroid, draining lymph nodes and involved adjacent structures.6 Guidelines for the Surgical Management of Endocrine Disease *A tumour of 1 cm diameter or less with no palpable lymphadenopathy or clinically overt disease in the contralateral lobe or evidence of distant metastases

2003 British Association of Endocrine and Thyroid Surgeons

10565. Effects of Head Elevation on Intracranial Pressure in Children

Details Study Description Go to Brief Summary: Head injury is the most common cause of mortality and acquired disability in childhood. It is common to elevate the head of patients at risk for increased intracranial pressure, although it is not clear if it is always beneficial. Every severe pediatric traumatic brain injured patient will have an optimal head position that prevents rising pressure in the brain. Condition or disease Intervention/treatment Phase Head Injury Procedure: Place HOB (...) in alternate positions from 0-50 degrees. Not Applicable Detailed Description: Head injury is the most common cause of mortality and acquired disability on childhood. Management of children at risk for intracranial hypertension is both complex and increasingly controversial. Also, effect of head position on intracranial pressure, cerebral perfusion pressure, adn cerebral venous outflow in the pediatric population has not been studied. We will examine the effect of head positioning on ICP, CPP, and cerebral

2008 Clinical Trials

10566. The Frequency Forward Head Posture in Subjects With Temporomandibular Disorder

The Frequency Forward Head Posture in Subjects With Temporomandibular Disorder The Frequency Forward Head Posture in Subjects With Temporomandibular Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) muscles and bones are lined up and work together in a harmonious form protecting the body of injury or gradual deformity and independently the attitude. The bad posture is a bad habit, but it can be which results in the disagreement of some parts of the body. These are at risk of injury or pain due to and increased tension that the disagreement imposes to the support structures. Several study confirm this occurrence relating that this the attitude can alter itself principally if a discomfort occurs

2008 Clinical Trials

10567. Radiation Therapy, Carboplatin, and Paclitaxel With or Without Amifostine in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer

Radiation Therapy, Carboplatin, and Paclitaxel With or Without Amifostine in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer Randomized Amifostine For SCCHN - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) Radiation: radiation Phase 2 Detailed Description: Amifostine is a drug that is used to treat moderate to severe xerostomia (dry mouth) for those who receive radiation therapy for head and neck cancer. It was approved by the FDA for use intravenously. This study plans to examine the effects of xerostomia when Amifostine is used subcutaneously (by injection). Amifostine has been seen to be effective when used to combat the effects of dry mouth, but also has some side effects which are listed later

2004 Clinical Trials

10568. Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer

Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) , unstable angina, congestive heart failure, or serious arrhythmia requiring medication Hypercalcemia related to head and neck cancer Brain metastasis Current peripheral neuropathy >= grade 2 at time of randomization Patients have co-existing condition that would preclude full compliance with the study Known hypersensitivity to ZD1839 (Iressa, gefitinib) or any excipients of this product; prior history of severe hypersensitivity reaction to Docetaxel or other drugs formulated with polysorbate 80 HIV

2004 Clinical Trials

10569. BION Treatment of Dysphagia After Radical Head-Neck Surgery

BION Treatment of Dysphagia After Radical Head-Neck Surgery BION Treatment of Dysphagia After Radical Head-Neck Surgery - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. BION Treatment of Dysphagia After (...) permanently ruin the swallowing apparatus. Thus, the majority of patients who undergo CRT develop severe swallowing problems, called dysphagia, that typically becomes worse by about 3-4 weeks following the beginning of CRT. In anticipation of all of these problems, subjects have a tube placed in the stomach (gastrostomy tube) so that they can be fed through the tube in the immediate postoperative period when the incision is fragile and when dysphagia develops during CRT. Clearly the management

2008 Clinical Trials

10570. Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer

Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) of these modalities. Radiotherapy treatment for head and neck cancer often causes severe late term side effects. Radiotherapy induced damage of the skin, lymphatic system, cartilage and bone often leads to symptoms such as trismus, lymphoedema, decreased range of motion of the mouth, neck and tongue, difficulty in using the mimic muscles, difficulty in swallowing and pain. The severity of late side effects due to radiotherapy treatment for head and neck cancer often leaves the patients with a poor quality of life

2008 Clinical Trials

10571. A Clinical Investigation of the Copelandâ„¢ Humeral Resurfacing Head

A Clinical Investigation of the Copelandâ„¢ Humeral Resurfacing Head A Clinical Investigation of the Copeland™ Humeral Resurfacing Head - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Clinical (...) Investigation of the Copeland™ Humeral Resurfacing Head The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00698750 Recruitment Status : Terminated (Sponsor terminated study early due to limited enrollment and follow-up.) First Posted : June 17, 2008 Last Update Posted : June 21, 2017 Sponsor: Biomet

2008 Clinical Trials

10572. Study of Eye Pressure as a Predictor of Intracranial Pressure in the Acutely Head-Injured Population

24, 2007 Sponsor: Ohio State University Information provided by: Ohio State University Study Details Study Description Go to Brief Summary: The purpose of this study is to determine if the pressure in the eye of a severely head-injured person correlates with the pressure in the person's skull. This is a prospective study of patients aged 18 and older who have experienced a traumatic closed head injury and are intubated either before or during the time they are in the Emergency Department (ED (...) ventilation pose a significant challenge to assess neurologically, as they are almost always sedated and often chemically paralyzed to facilitate airway management. Therefore, it is in this population of intubated trauma patients with suspected head injury that we will evaluate the use of tonometry to predict intracranial pressure from intraocular pressure. Study Design Go to Layout table for study information Study Type : Observational Actual Enrollment : 37 participants Observational Model: Defined

2007 Clinical Trials

10573. Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00588770 Recruitment Status : Active

2007 Clinical Trials

10574. Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study (...) the severity of mucositis, or mouth sores, in patients receiving radiation therapy and chemotherapy for head and neck cancer. It is not yet known whether palifermin is more effective than a placebo in lessening mucositis in patients receiving radiation therapy and chemotherapy for head and neck cancer. PURPOSE: This randomized phase III trial is studying palifermin to see how well it works compared to a placebo in lessening oral mucositis in patients undergoing radiation therapy and chemotherapy

2006 Clinical Trials

10575. GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) mucoepidermoid carcinoma of the oral cavity Additional relevant MeSH terms: Layout table for MeSH terms Head and Neck Neoplasms Mucositis Radiation Injuries Neoplasms by Site Neoplasms Gastroenteritis Gastrointestinal Diseases Digestive System Diseases Mouth Diseases Stomatognathic Diseases Wounds and Injuries Sargramostim Immunologic Factors Physiological Effects of Drugs

2006 Clinical Trials

10576. A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00409565 Recruitment Status : Completed First Posted : December 11, 2006 Results

2006 Clinical Trials

10577. Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck

Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00392665 Recruitment Status : Terminated (slow accrual) First Posted : October 26, 2006 Results First Posted : March 14, 2017 Last Update Posted

2006 Clinical Trials

10578. Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00409565 Recruitment Status : Completed First Posted : December 11, 2006 Results First Posted

2006 Clinical Trials

10579. Anaesthesia With Propofol Versus Midazolam : Effect on Oxidative Stress in the Brain of Head Trauma Patients

Anaesthesia With Propofol Versus Midazolam : Effect on Oxidative Stress in the Brain of Head Trauma Patients Anaesthesia With Propofol Versus Midazolam : Effect on Oxidative Stress in the Brain of Head Trauma Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) Last Update Posted : March 2, 2012 Sponsor: Rennes University Hospital Collaborator: Ministry of Health, France Information provided by (Responsible Party): Rennes University Hospital Study Details Study Description Go to Brief Summary: Severe traumatic brain injury is associated with an increased production of free radicals causing brain damage. First line treatment of these patients aims to maintain cerebral perfusion and includes deep anaesthesia. Propofol has recently shown anti oxidant

2006 Clinical Trials

10580. Bilateral Radial Head Fractures in a Woman With Trivial Trauma Full Text available with Trip Pro

Bilateral Radial Head Fractures in a Woman With Trivial Trauma Radial head fractures are common injuries, occurring in about 20% of all acute elbow injuries. Isolated radial head fractures are not common and include about 2% of all fractures around the elbow. Bilateral radial head fractures are rare and usually associated with severe trauma and associated fractures and dislocations. We report a case of bilateral undisplaced radial head fracture in a woman, following a simple fall. Early (...) recognition, proper management, and physical therapy led to complete recovery and full functional movement of the elbow.

2005 Medscape General Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>